A nine-site observational study found that semaglutide use in people with HIV did not lead to significant increases in depressive symptoms, contrary to some concerns; this is important for treatment decisions involving diabetes and weight loss management in HIV patients.
Read the full article at MedPage Today
This is a brief trending article summary.
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



